Search Results - "Koucká, Kamila"

Ketone-selenoesters as potential anticancer and multidrug resistance modulation agents in 2D and 3D ovarian and breast cancer in vitro models by Dobiasová, Simona, Szemerédi, Nikoletta, Kučerová, Denisa, Koucká, Kamila, Václavíková, Radka, Gbelcová, Helena, Ruml, Tomáš, Domínguez-Álvarez, Enrique, Spengler, Gabriella, Viktorová, Jitka

“…Long-term treatment of cancer with chemotherapeutics leads to the development of resistant forms that reduce treatment options. The main associated mechanism…”
Get full text

Multidrug Resistance Modulation Activity of Silybin Derivatives and Their Anti-inflammatory Potential by Dobiasová, Simona, Řehořová, Kateřina, Kučerová, Denisa, Biedermann, David, Káňová, Kristýna, Petrásková, Lucie, Koucká, Kamila, Václavíková, Radka, Valentová, Kateřina, Ruml, Tomáš, Macek, Tomáš, Křen, Vladimír, Viktorová, Jitka

“…Silybin is considered to be the main biologically active component of silymarin. Its oxidized derivative 2,3-dehydrosilybin typically occurs in silymarin in…”
Get full text

The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes by Seborova, Karolina, Kloudova-Spalenkova, Alzbeta, Koucka, Kamila, Holy, Petr, Ehrlichova, Marie, Wang, Changwei, Ojima, Iwao, Voleska, Iveta, Daniel, Petr, Balusikova, Kamila, Jelinek, Michael, Kovar, Jan, Rob, Lukas, Hruda, Martin, Mrhalova, Marcela, Soucek, Pavel, Vaclavikova, Radka

“…The main problem precluding successful therapy with conventional taxanes is de novo or acquired resistance to taxanes. Therefore, novel experimental taxane…”
Get full text

Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model by Seborova, Karolina, Koucka, Kamila, Spalenkova, Alzbeta, Holy, Petr, Ehrlichova, Marie, Sychra, Tomas, Chen, Lei, Bendale, Hersh, Ojima, Iwao, Sandoval-Acuña, Cristian, Truksa, Jaroslav, Soucek, Pavel, Vaclavikova, Radka

“…Taxanes are widely used in the treatment of ovarian carcinomas. One of the main problems with conventional taxanes is the risk of development of multidrug…”
Get full text

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome by Tomasova, Kristyna, Cumova, Andrea, Seborova, Karolina, Horak, Josef, Koucka, Kamila, Vodickova, Ludmila, Vaclavikova, Radka, Vodicka, Pavel

“…There is ample evidence for the essential involvement of DNA repair and DNA damage response in the onset of solid malignancies, including ovarian cancer…”
Get full text

Association of lncRNA and transcriptome intersections with response to targeted therapy in metastatic renal cell carcinoma by Tesarova, Tereza, Koucka, Kamila, Vaclavikova, Radka, Seborova, Karolina, Hora, Milan, Hes, Ondrej, Pivovarcikova, Kristyna, Soucek, Pavel, Fiala, Ondrej

“…Long non-coding RNAs (lncRNAs) serve an important role in cancer progression and may be used as efficient molecular biomarkers. The present study aimed to…”
Get full text